Medtronic has received CE marking for the latest addition to its CoreValve family of transcatheter aortic valves. The CoreValve System has been designed to provide a minimally invasive treatment option for patients with symptomatic, severe aortic stenosis who are at high risk, or are ineligible, for open-heart surgery.
According to the press release, the new 31mm CoreValve system is the largest transcatheter valve available and can be deployed through the same delivery system as smaller CoreValve sizes. Individual valve sizing is essential for achieving ideal patient blood flow and for minimizing the risk of adverse events.
Medtronic’s CoreValve family now includes 26mm, 29mm and 31mm valve sizes – all based on the self-expanding platform that was CE marked in 2007. To date CoreValve System has been implanted in over 15,000 patients in more than 40 countries. The CoreValve System is currently limited to investigational use in the United States.
Press release: Medtronic Gains CE Mark for 31mm CoreValve® Percutaneous Aortic Valve …
Product page: The CoreValve System …
Previous coverage of CoreValve at Medgadget…